Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Neurol Neurosci Rep. 2002 Jan;2(1):89-95.

Advances in myasthenia gravis.

Author information

  • 1Duke University Medical Center, 932 Morreene Road, Room 230, Durham, NC 27705, USA. ciafa001@mc.duke.edu

Abstract

Recent advances in the diagnosis and treatment of acquired myasthenia gravis (MG) are reviewed. Increased awareness about the need for more uniform methods of reporting treatment trials for MG has prompted systematic review of the literature and inspired an effort to develop better classifications and disease-specific outcome measures. New antibodies have been discovered in patients with seronegative MG, possibly defining an immunologically distinct form of the disease. A new immunosuppressant, mycophenolate mofetil, may be an additional and safe option in the treatment of MG. Other work supports the possibility of developing a vaccine against MG suitable for trial in humans.

PMID:
11898588
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk